Gilead Sciences Inc (GILD)

pos +1.73
Today's Range: 101.07 - 104.51 | GILD Avg Daily Volume: 17,435,800
Last Update: 01/29/15 - 4:00 PM EST
Volume: 8,372,006
YTD Performance: 8.69%
Open: $102.50
Previous Close: $102.45
52 Week Range: $63.50 - $116.83
Oustanding Shares: 1,508,664,333
Market Cap: 158,455,014,895
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 12 12 12
Moderate Buy 2 2 2 2
Hold 3 3 3 2
Moderate Sell 1 1 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.65 1.61 1.47 1.38
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 18.62
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
18.62 18.60 25.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-9.70% 27.00% 320.57%
Revenue 15.50 0.41 0.12
Net Income 18.80 0.06 0.02
EPS 10.80 0.18 0.06
Earnings for GILD:
Revenue 11.20B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $2.36 $3.49 $7.80 $10.51
Number of Analysts 2 1 2 2
High Estimate $2.36 $3.49 $7.91 $11.88
Low Estimate $2.36 $3.49 $7.69 $9.13
Prior Year $0.52 $1.44 $1.92 $7.80
Growth Rate (Year over Year) 353.85% 142.36% 306.25% 34.68%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Getting Defensive Now Real Money Pro($)

I am adding allocation to healthcare.
These are surefire indications of a bountiful tape.
Jan 13, 2015 | 6:41 AM EST
JPMorgan Healthcare Conference (Day 2 of 4) - 01/12/15 - 01/15/15 San Francisco, CA
Watch the share count when looking at earnings.

Braving Biotech Real Money Pro($)

Do you need to pick one name?
They are prone to being whipsawed by news.

Why I'm Sticking With Biotech Real Money Pro($)

They offer a nice shelter for the headwinds now hitting equities.
If the market gaps down in the morning, watch for the dip buyers.
Did my portfolio pass muster?
Its hepatitis C drug will dominate the market.

Columnist Conversations

January 29, 2015, 4:34 P.M. ET "Where Did That Come From? Dow Jumps 225 Points, S&P 500 Gains 1% For No Go...
There is a small bullish MacD divergence on the daily Energy Select Sector SPDR (XLE) chart and with what look...
Remember IF that last low in LNKD is good, we should hold on a pullback to it....Note we are holding that supp...
Auditor of REITs in American Realty Capital Resigned The Grant Thornton accounting firm resigned as the audito...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.